The potential mechanism of treating IC/BPS with hyperbaric oxygen by reducing vascular endothelial growth inhibitor and hypoxia-inducible factor-1α.

Published in: Turkish journal of medical sciences (2023)

This study identified a possible mechanism by which VEGI and HIF-1α expression decreased after HBO treatment due to hypoxia reversal, which improved symptoms in IC/BPS patients.

Keyphrases

end stage renal disease
endothelial cells
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
binding protein
human health
replacement therapy